Basic Information
Implant Therapeutics is a subsidiary of panCELLa. Its mission is to develop therapeutic products in the fields of immunology, mesenchymal stem cells, and islet space, and to collaborate with other companies to develop new products in other areas of regenerative medicine. Under the guidance of Dr. Mahendra Rao, Implant Therapeutics is designing iPSC-MSC cells that incorporate panCELLa's FailSafe(TM) and induced allogeneic cell tolerance technologies, also known as iACT Stealth Cell(TM) technology. These iPSC-MSC cells have low immunogenicity and are ideal for bone, cartilage, and tendon replacement strategies, combining the advantages of both allogeneic and autologous cells and allowing them to be used as ex vivo gene therapy vectors.